MedTrace Logo

Study on the Effect of the Intake of a Calcium-bicarbonate Water on Cholesterol Levels

NCT07026266 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-05-11

No results posted yet for this study

Summary

The goal of this study is to evaluate the hypolipidemic effect (reduction of Low Density Lipoprotein Cholesterol "LDL-C" values) of calcium-bicarbonate mineral water "Lete" (alkaline water, high in bicarbonate and calcium ions and low in sodium) compared to control oligomineral water "Sorgesana" on healthy volunteers

Conditions

Interventions

OTHER

Water

Calcium-bicarbonate mineral water "Lete"

OTHER

Water

Oligomineral water "Sorgesana"

Sponsors & Collaborators

  • Società Generale delle Acque Minerali S.p.A.

    lead INDUSTRY

Principal Investigators

  • Alberto Margonato · Hospital San Raffaele - Milano (Italy)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-17
Primary Completion
2026-04-03
Completion
2026-04-03

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07026266 on ClinicalTrials.gov